News

Janice Chen co-founded Mammoth Biosciences after inventing a powerful gene detection tool in grad school. Now she's helping ...
User Agreement; Privacy Policy; Ad Choices; Site Map © 2025 American City Business Journals. All rights reserved. Use of ...
CHICAGO (AP) — Julio Rodríguez hit a grand slam, Luis Castillo pitched seven crisp innings and the Seattle Mariners beat the ...
Pharmaceutical and semiconductor manufacturing must form part of EU-US talks on trade, Taoiseach Micheál Martin has said. His comments come as it was confirmed Ireland is the second biggest ...
Former hedge fund manager Martin Shkreli cast doubt on recent quantum ... Shkreli, who gained notoriety as “Pharma Bro” and was convicted of securities fraud in 2017, remains banned from ...
Controversial figure Martin Shkreli issued a stark warning ... What Happened: Shkreli, popularly known as “Pharma Bro,” took to X to vent his thoughts on MicroStrategy’s ongoing downturn ...
Pakistan’s pharmaceutical companies Citi Pharma Limited (CPHL), Martin Dow, and Chinese pharmaceutical giant Kingbo Pharmatec, have signed a Memorandum of Understanding (MoU) to develop and ...
US federal judge Pamela Chan has ordered Martin Shkreli "Pharma Bro" to turn over any and all copies he possesses of an ultra-rare Wu-Tang Clan album "Once Upon A Time in Shaolin" from 2015.
Convicted felon and ex-pharmacy profiteer Martin Shkreli has been ordered to surrender all his copies of a one-off Wu-Tang Clan album he used to own, ArtNet reported. The preliminary injunction ...
Martin Shkreli's lifetime ban from the pharmaceutical industry was upheld by a federal appeals court in New York on Tuesday. A three-judge panel of the 2nd U.S. Circuit Court of Appeals ruled ...
Martin Shkreli, the notorious former CEO of Turing Pharmaceuticals and convicted securities fraudster, will still be banned from working in the pharmaceutical industry after a federal appeals ...
Shkreli was released from prison in May 2022. Martin Shkreli's lifetime ban from the pharmaceutical industry was upheld by a federal appeals court in New York on Tuesday. A three-judge panel of ...